Orforglipron: The $10B Weight-Loss Pill Race
Update: 2025-09-17
Description
Weight-loss pill race heats up! Eli Lilly's orforglipron could be a game-changer, but will they use the FDA's new fast-track? Find out why Wall Street is buzzing about potential billions, the global manufacturing plans, and how this pill stacks up against Novo Nordisk's contender in the battle against obesity.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
